miR-29b is an indicator of prognosis in breast cancer patients
نویسندگان
چکیده
منابع مشابه
Expression Analysis of Cellular Mir-29a and mir-29b in HIV Positive Patients
Abstract Background and Objective: Various cellular factors affect the process of HIV activity. One of these cellular factors are structures known as microRN that are expected to be involved in controlling HIV replication and infectivity. The expression of one or a set of them may represent the patient's clinical conditions. In this study, ...
متن کاملDecreased expression of miR-204 is associated with poor prognosis in patients with breast cancer.
The identification of biomarkers in breast cancer diagnosis and therapy is important in achieving early cancer diagnosis and improving patient outcomes. The aim of this study was to examine clinical significance of miR-204 expression in tissues from breast cancer patients. The relationship between miR-204 expression and clinicopathological characteristics was investigated. MiR-204 expression wa...
متن کاملPlatelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
Platelet-lymphocyte ratio (PLR) is a hematological parameter which is investigated as a biomarker for prognosis in patients with breast cancer. Due to the controversial results from previous studies, we performed a meta-analysis. Databases of PubMed, Embase and Web of Science were searched to identify eligible studies. STATA version 12.0 was used for statistical analysis. Seven studies with 3,7...
متن کاملMir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer.
OBJECTIVE MiR-595 has been demonstrated to be involved in tumorigenesis of several cancers. However, the clinical significance of miR-595 in epithelial ovarian cancer (EOC) remains unclear. The aim of this study was to explore the correlation of miR-595 expression with clinicopathologic features and prognosis in EOC patients. PATIENTS AND METHODS Quantitative Real-time PCR (qRT-PCR) was perfo...
متن کاملmiR-29b
Multiple myeloma (MM) is a heterogeneous disease originating from the transformation of a post-germinal center B cell. MM pathogenesis is a multistep process with chro-mosomal changes, genetic and epigenetic events occurring at different stages during the course of the disease. 1 MicroRNAs (miRNAs) are well known to be transcriptional repressors, possessing tumor suppressor (Ts) or oncogenic fu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular and Clinical Oncology
سال: 2015
ISSN: 2049-9450,2049-9469
DOI: 10.3892/mco.2015.565